AWD 52-39
AWD 52-39, or AWD-5239, also known as N,N-diacetoxyethyl-9,10-dihydrolysergamide, is a drug described as a "nootropic" (cognitive enhancer) of the lysergamide family related to lysergic acid diethylamide (LSD) that was never marketed.
≈ 2 min read
AWD 52-39. encyclopegia.org, snapshot enwiki-001370316623. /a/awd-52-39
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
AWD 52-39, or AWD-5239, also known as N,N-diacetoxyethyl-9,10-dihydrolysergamide, is a drug described as a "nootropic" (cognitive enhancer) of the lysergamide family related to lysergic acid diethylamide (LSD) that was never marketed. It was under development by Arzneimittelwerk Dresden, but development was discontinued. The effects of AWD 52-39 in preclinical studies have been reported.
It has been described as a serotonin 5-HT 2 receptor antagonist. The drug has been found to enhance learning and memory and to produce antidepressant-like effects in rodents. It appears to act upon vascular serotonin receptors.
The chemical synthesis and stereochemistry of AWD 52-39 have been described. The drug was first described in the scientific literature by 1989. It reached phase 2 clinical trials for the treatment of cognition disorders prior to the discontinuation of its development.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1370316623 under CC BY-SA 4.0; modifications have been made.